Literature DB >> 6583314

Eye movements in amyotrophic lateral sclerosis.

B Cohen, J Caroscio.   

Abstract

It has generally been assumed that the oculomotor system is not involved in amyotrophic lateral sclerosis (ALS). However, reports from the literature and recent experience with patients indicate that there are oculomotor abnormalities in some ALS patients. These appear to fall into two main categories. One group of patients has signs that reflect damage or degeneration in cortico-oculomotor pathways. These patients have problems in generating voluntary saccades, convergence and pursuit eye movements. It should be possible to corroborate deficits in ocular pursuit in these patients with deficits in visual suppression of the vestibulo-ocular reflex (VOR) and in optokinetic nystagmus (OKN). A second group of patients, much less common than the first, has a more global type of ophthalmoplegia, probably reflecting a loss of neurons in and around the ocular motor nuclei. There are probably also patients with mixed types of involvement. Testing the vestibulo-ocular reflex (VOR) in conjunction with other tests of visual-oculomotor function should help in identifying the deficits. The relative incidence of the various types of deficits is not known and is a subject for study. It would also be of interest to correlate the changes that are present in the oculomotor system of patients with ALS with deficits in other parts of the somatic motor system.

Entities:  

Mesh:

Year:  1983        PMID: 6583314

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  10 in total

1.  Does the 'P300' speller depend on eye gaze?

Authors:  P Brunner; S Joshi; S Briskin; J R Wolpaw; H Bischof; G Schalk
Journal:  J Neural Eng       Date:  2010-09-21       Impact factor: 5.379

2.  Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population.

Authors:  Heather E Moss; Leo McCluskey; Lauren Elman; Katelin Hoskins; Lauren Talman; Murray Grossman; Laura J Balcer; Steven L Galetta; Grant T Liu
Journal:  J Neurol Sci       Date:  2011-12-21       Impact factor: 3.181

3.  Toward a high-throughput auditory P300-based brain-computer interface.

Authors:  D S Klobassa; T M Vaughan; P Brunner; N E Schwartz; J R Wolpaw; C Neuper; E W Sellers
Journal:  Clin Neurophysiol       Date:  2009-07-01       Impact factor: 3.708

4.  Oculomotor abnormalities in motor neuron disease.

Authors:  J Marti-Fàbregas; C Roig
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

5.  Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators.

Authors:  T Mizutani; S Sakamaki; N Tsuchiya; S Kamei; H Kohzu; R Horiuchi; M Ida; R Shiozawa; T Takasu
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28

7.  Rapid Communication with a "P300" Matrix Speller Using Electrocorticographic Signals (ECoG).

Authors:  Peter Brunner; Anthony L Ritaccio; Joseph F Emrich; Horst Bischof; Gerwin Schalk
Journal:  Front Neurosci       Date:  2011-02-07       Impact factor: 4.677

8.  A Gaze Independent Brain-Computer Interface Based on Visual Stimulation through Closed Eyelids.

Authors:  Han-Jeong Hwang; Valeria Y Ferreria; Daniel Ulrich; Tayfun Kilic; Xenofon Chatziliadis; Benjamin Blankertz; Matthias Treder
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

9.  Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as neuroprotective agents.

Authors:  Kopal Joshi; Sukriti Goyal; Sonam Grover; Salma Jamal; Aditi Singh; Pawan Dhar; Abhinav Grover
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

10.  Overstimulation of the inhibitory nervous system plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis.

Authors:  Bert Tuk
Journal:  F1000Res       Date:  2016-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.